...
机译:用于转移黑色素瘤的抗PD1免疫疗法的预后和治疗剂18F-FDG PET生物标志物:与结果和转录组织相关联
Univ Paris Saclay Gustave Roussy Dept Imagerie Med F-94800 Villejuif France;
Columbia Univ Dept Med Med Ctr Div Hematol Oncol New York Presbyterian Hosp New York NY USA;
Gustave Roussy Drug Dev Dept DITEP Villejuif France;
Columbia Univ Med Ctr New York Presbyterian Hosp Dept Radiol New York NY 10039 USA;
Gustave Roussy Drug Dev Dept DITEP Villejuif France;
Univ Paris Saclay Gustave Roussy Dept Imagerie Med F-94800 Villejuif France;
Gustave Roussy Canc Campus Melanoma Grp INSERM U981 Villejuif France;
Columbia Univ Med Ctr New York Presbyterian Hosp Dept Radiol New York NY 10039 USA;
Columbia Univ Dept Med Med Ctr Div Hematol Oncol New York Presbyterian Hosp New York NY USA;
Columbia Univ Dept Med Med Ctr Div Hematol Oncol New York Presbyterian Hosp New York NY USA;
Columbia Univ Dept Med Med Ctr Div Hematol Oncol New York Presbyterian Hosp New York NY USA;
Gustave Roussy Drug Dev Dept DITEP Villejuif France;
Columbia Univ Med Ctr New York Presbyterian Hosp Dept Radiol New York NY 10039 USA;
Columbia Univ Dept Med Med Ctr Div Hematol Oncol New York Presbyterian Hosp New York NY USA;
Gustave Roussy Canc Campus Melanoma Grp INSERM U981 Villejuif France;
Columbia Univ Med Ctr New York Presbyterian Hosp Dept Radiol New York NY 10039 USA;
Metastatic melanoma; FDG-PET; CT; Prognosis; Metabolic tumor burden; Systemic inflammatory response; Immune checkpoint inhibitors;
机译:用于转移黑色素瘤的抗PD1免疫疗法的预后和治疗剂18F-FDG PET生物标志物:与结果和转录组织相关联
机译:预后和预测性生物标志物对转移性黑色素瘤患者免疫治疗的益处
机译:预后和预测性生物标志物对转移性黑色素瘤患者免疫治疗的益处
机译:PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
机译:预测转移性黑色素瘤中抗PD-1免疫疗法的反应。
机译:应对转移性黑素瘤患者抗PD1免疫疗法的预治疗突变和转录组
机译:引起小肠肠套叠的转移性黑色素瘤:18F-FDG pET / CT诊断转移性黑色素瘤引起小肠肠套叠:18F-FDG pET / CT诊断